Nigeria’s equities market in 2025 mirrored a yr of exceptional resilience, strategic execution, and selective sectoral momentum.
Regardless of financial headwinds, shares throughout a number of sectors surged, pushed by earnings energy, improved liquidity, and reform-induced investor confidence.
Based on information compiled by Nairametrics from the Nigerian Change Restricted (NGX), no fewer than 45 listed firms posted features of over 100%, with some shares returning greater than 1,000% in a record-setting yr.
It was a comparatively good yr, with the All-Share Index (ASI) settling at 155,613.03 factors, delivering a 51.19% year-to-date acquire. Market capitalisation additionally expanded strongly, rising to N99.38 trillion by year-end. This marked a year-on-year improve of roughly 58.4%, in contrast with the N62.76 trillion market capitalisation recorded as of December 31, 2024.
Past the headline numbers, these exceptional inventory features had been pushed by the imaginative and prescient, technique, and execution of the executives on the helm. From prescribed drugs to manufacturing, insurance coverage, and expertise, the top-performing firms of the yr had been led by CEOs and Managing Administrators whose management impressed operational excellence and investor confidence.
Share worth progress is usually the clearest reflection of efficient management, and 2025 offered a vivid showcase of executives turning technique into tangible market outcomes.
What follows is Nairametrics’ curated record of top-performing CEOs and Managing Administrators of the yr leaders who drove commendable market returns by imaginative and prescient, self-discipline, and execution.
Efficiency- N50.10(+223%)
Biola Adebayo is the Managing Director and CEO of Fidson Healthcare Plc, bringing over three many years of expertise within the pharmaceutical sector.
He graduated from the School of Pharmacy, University of Lagos (1988) and holds a Diploma in Superior Pc Strategies and Purposes from the University of Ibadan.
Adebayo started his profession at Glaxo Nigeria Plc in 1991 and later joined CAP Plc, honing his experience in gross sales and advertising and marketing. He joined Fidson Healthcare Plc in 1996, rising by the ranks from Gross sales and Advertising Supervisor (2001) to Gross sales and Advertising Director (2004), Operations and Technical Director, Deputy Managing Director (2022), and finally CEO.
He’s a fellow of the Pharmaceutical Society of Nigeria and a monetary member of the Institute of Administrators (IOD). Mr. Adebayo has accomplished government packages at Manchester Enterprise School, Lagos Enterprise School, IESE, Yale School of Administration, and the African International CEO Programme.
Throughout his tenure, Fidson Healthcare Plc made certainly one of its most consequential capital market strikes in recent times with the formal launch of a N21 billion Rights Situation in 2025.
Beneath his management, Fidson Healthcare Plc delivered a powerful re-rating in 2025, with its share worth rising from N15.75 firstly of the yr to N50.10 by year-end, translating right into a 223% return for buyers.
This rally drove the corporate’s market capitalisation increased, increasing from N35.57 billion in December 2024 to N114.98 billion by December 2025, additionally representing a 223% improve.
Be First to Comment